Host Hotels & Resorts Inc. Common Stock vs Eli Lilly And Co — how do they compare? Host Hotels & Resorts Inc. Common Stock trades at $22.57 (market cap $15.24B), while Eli Lilly And Co trades at $1,167.38 (market cap $1.06T). The key difference: Eli Lilly And Co is far larger — about 69.6× Host Hotels & Resorts Inc. Common Stock's market cap, and Host Hotels & Resorts Inc. Common Stock pays the higher dividend (3.6%). Which is the better fit depends on your goals — on Pluang, investors hold Host Hotels & Resorts Inc. Common Stock for 0 Days and Eli Lilly And Co for 93 Days on average.
| HST | LLY | |
|---|---|---|
Market Cap | $15.24B | $1.06T |
Volume | 4,815,258 | 2,297,239 |
Sector | Real Estate | Health |
52-Week High | $25.54 | $1.28K |
52-Week Low | $15.82 | $799.57 |
Typical Hold Time | 0 Days | 93 Days |
Enterprise Value | $18.93B | $1.11T |
Dividend Yield | 3.6% | 0.58% |
Signals from Pluang's Aura AI — not financial advice
No Aura AI signal available yet.
Eli Lilly (LLY) trades at $1,188.72, up 2.7% on the day, with a bullish technical signal and strong fundamentals. Recent earnings beats, robust revenue growth to $65.18B in 2025, and a net income margin of 33.53% highlight operational strength. Positive news flow centers on next-generation weight-loss drugs, with analyst consensus bullish and a price target of $1,350.
Outlook remains positive given pipeline catalysts in obesity/diabetes markets, though high valuations (P/E 39.9) and rising debt levels pose risks. Competitive intensity and regulatory scrutiny are watchpoints, but institutional support and earnings momentum underpin further upside potential.
Trailing returns across standard periods
What Pluang investors did over the last 30 days
Latest headlines on both assets
Host Hotels & Resorts is a real estate investment trust that owns luxury and upscale hotel properties. Its portfolio includes hotels operated under major global brands.
Read more on HST →Eli Lilly is a drug firm with a focus on neuroscience, endocrinology, cancer, and immunology. Lilly's key products include Verzenio for cancer
Read more on LLY →